Integrated Biopharma Inc Q1 FY2026 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2026 Q1 Call date: 2025-11-10 Concluded

Quarter scorecard

Revenue

$12.69M

-6.8% YoY

Diluted EPS

$0.00

-100% YoY

Gross margin

8.0%

-2.1 pp YoY

Net income

$123,000

-52.5% YoY

Contract Manufacturing $12.17M

-6.2%

Other Nutraceutical Business $522,000

-18.9%